Tag: highly variable drugs

30 Jan 2026

11 Comments

Replicate Study Designs: Advanced Methods for Bioequivalence Assessment

Replicate study designs are essential for assessing bioequivalence of highly variable drugs. They reduce sample sizes, improve success rates, and enable regulatory acceptance through reference-scaling. Learn which design to use, how to avoid common pitfalls, and what the industry is doing in 2026.